Your new post is loading...
New research from Yale University reveals that the experimental cancer drug AZD05030 blocks damage triggered during the formation of amyloid-beta plaques, restoring synaptic connections and memory in a mouse model of Alzheimer's.
Memory and as well as connections between brain cells were
Another Big Deal! JB